Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes.

Saved in:
Bibliographic Details
Title: Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes.
Authors: Singh I; Department of Neurology, Liverpool Hospital, Sydney, NSW 2170, Australia., Issar T; School of Clinical Medicine, University of New South WalesSydney, Kensington, NSW 2033, Australia., Poynten AM; Department of Endocrinology, Prince of Wales Hospital, Sydney, NSW 2031, Australia., Milner KL; Department of Endocrinology, Prince of Wales Hospital, Sydney, NSW 2031, Australia., Krishnan AV; School of Clinical Medicine, University of New South WalesSydney, Kensington, NSW 2033, Australia.; Department of Neurology, Prince of Wales Hospital, Sydney, NSW 2031, Australia., Dhanapalaratnam R; School of Clinical Medicine, University of New South WalesSydney, Kensington, NSW 2033, Australia.; Department of Neurology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Source: Biomedicines [Biomedicines] 2024 Nov 04; Vol. 12 (11). Date of Electronic Publication: 2024 Nov 04.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2227-9059
DOI:10.3390/biomedicines12112518